Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Warner-Lambert discloses ACAT inhibitors

April 5, 1996

BMS claims beta3 agonists in patent literature

April 5, 1996

ACAT inhibitors claimed by DuPont Merck

April 5, 1996

Kyowa Hakko discloses UCF76-B

April 5, 1996

New angiogenesis inhibitors from ADIR

April 5, 1996

Merck & Co. reports farnesyl transferase inhibitors

April 5, 1996

Antineoplastic fusion proteins from Bristol-Myers Squibb

April 5, 1996

MAbs for treatment of melanoma

April 5, 1996

BMS reports mutant BR96 antibodies

April 5, 1996

Yakult Honsha claims camptothecin derivatives

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...